Image

Global Oral Electrolyte Solutions Market – Industry Trends and Forecast to 2029

  • Pharmaceutical
  • Upcoming Report
  • Sep 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60
  • Pharmaceutical
  • Upcoming Report
  • Sep 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Oral Electrolyte Solutions Market, By Type (Orange, Lemonadex, Others), Indication (Diarrhea, Vomiting, Others), Application (Infants, Children, Adults), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2029

Oral Electrolyte Solutions Market

Oral Electrolyte Solutions Market Analysis and Size

The global oral electrolyte solutions market is expected to witness significant growth during the forecast period. Growing cases of electrolyte loss during dehydration drives the oral electrolyte solutions market. Moreover, easily available ORS as OTC drugs and increased awareness will enhance the oral electrolyte solutions market. COVID-19 also had a major impact on the market growth.

Data Bridge Market Research analyses a growth rate in the global oral electrolyte solutions market in the forecast period 2022-2029. The expected CAGR of global oral electrolyte solutions market is tend to be around 13% in the mentioned forecast period. The market was valued at USD 10.15 billion in 2021, and it would grow upto USD 27 billion by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Market Definition

Oral electrolyte solutions are widely used for rehydration in diarrheal and vomiting conditions to maintain the body's hydration or electrolyte balance. In diarrheal illness oral rehydration solution preferred over the parenteral solution except patients with severe dehydration of illness. It is of great importance to the healthcare sector and it is expected to grow in the forecast period.  

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2014 - 2019)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Type (Orange, Lemonadex, Others), Indication (Diarrhea, Vomiting, Others), Application (Infants, Children, Adults), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Johnsons & Johnsons Pvt Ltd (U.S.), Boehringer Ingelheim International GmbH (U.S.), Allergan (U.S.), Sun Pharmaceutical Industries Ltd. (India), Sanofi (France), Novartis AG (Switzerland), Pfizer Inc. (U.S.), Amneal Pharmaceuticals LLC. (U.S.), Mylan N.V. (U.S.), Janssen Pharmaceuticals, Inc. (Belgium), Bristol Myers Squibb Company (U.S.), Bayer AG (Germany), Healthy Life Pharma Private Limited (India), Drip Drop Hydration Inc. (U.S.), Otsuka America Pharmaceutical, Inc (Japan), Pendopharm (Canada)

Market Opportunities

  • Increased Product Launches
  • Increasing Demand for Retail Pharmacies

Global Oral Electrolyte Solutions Market Dynamics

Drivers

  • Increase in Diarrhea

Diarrhea is one of the major driving factors for the oral electrolyte solutions market. Oral electrolyte solutions are majorly preferred over intravenous fluids for most patients. According to Global Burden of Disease in November 2019, diarrheal disease witnessed to be the cause of every 10 children’s mortality in 2017 and more than half a million died in 2017 due to diarrheal disease. This boost the market growth.

  • The Changing Lifestyle Scenario

The increasing lifestyle is changing with the increased disposable income of people, making them spend more on ready-to-consume products, thus increasing the sales of oral electrolyte solutions. In addition to this, the rising health and awareness changes in consumer lifestyles are acting as the main driving point for the market's growth. More increasing sales are expected of oral electrolyte solutions in the forecast period.

Opportunities

  • Increased Product Launches

Rising product launches to diminish the rising diarrhoea cases is definitely helping to create more opportunities for the market. For instance, Pace Wellness, an innovator and manufacturer using an advanced, patented drug-delivery platform to make oral dissolvable pharmaceutical and nutraceutical products, launched Solves strips in April 2016. It is a pediatric electrolyte oral thin-film which serves as a great innovation for medicine delivery. These pediatric electrolyte strips are for children of 2 years and older to quickly replenish electrolytes and helps to gain fluid retention.

  • Increasing Demand for Retail Pharmacies

The rise in the number of narcotic drugs delivered through retail pharmacies and the surge in the number of retail pharmacies in developed countries create opportunities for the market growth. In addition to this, patients prefer retail pharmacies for purchasing drugs, as these are easily accessible.

 Restraints/Challenges

  • Lack of skilled professionals

The lack of qualified personnel who are unable to treat the patients with these agents could curb the growth of the global oral electrolyte solutions market over a forecast period.

  • High Cost

The huge expenditure associated with these agents surely hamper the market growth.

This global oral electrolyte solutions market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global oral electrolyte solutions market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global Oral Electrolyte Solutions Market            

Considering the present scenario, COVID-19 has left an unprecedented global public health crisis that has impacted practically every business. Its long-term repercussions are expected to influence industry growth during the forecast period. Transition of healthcare infrastructure toward managing COVID-19 has led to drug launch cancellations and delays in clinical trials.

In the post-pandemic era, more and more growth are witnessed as fatigue and diarrhea symptoms increase. The socioeconomic stressors have also boosted the demand for these drugs. Thus, this will leave a significant impact on the oral electrolyte solutions market.

Global Oral Electrolyte Solutions Market Scope

The global oral electrolyte solutions market is segmented on the basis of type, indication, application, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Orange
  • Lemonadex
  • Others

Indication

  • Diarrhea
  • Vomiting
  • Others

Application

  • Infants
  • Children
  • Adults

End User

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

Oral Electrolyte Solutions Market Regional Analysis/Insights

The global oral electrolyte solutions market is analysed and market size insights and trends are provided by type, indication, application, distribution channel and end-user as referenced above.

The major countries covered in the global oral electrolyte solutions market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America has been witnessing a positive growth for global oral electrolyte solutions market throughout the forecasted period due to the presence of skilled professionals, higher healthcare and R & D expenditure.

Asia-Pacific dominates the market due to increased awareness programmes by government authorities, pharmaceutical companies and WHO.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Oral Electrolyte Solutions Market Share Analysis

The global oral electrolyte solutions market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global oral electrolyte solutions market

Key players operating in the global oral electrolyte solutions market include:

  • Johnsons & Johnsons Pvt Ltd (U.S.)
  • Boehringer Ingelheim International GmbH (U.S.)
  • Allergan (U.S.)
  • Sun Pharmaceutical Industries Ltd. (India)
  • Sanofi (France)
  • Novartis AG (Switzerland)
  • Pfizer Inc. (U.S.)
  • Mylan N.V. (U.S.)
  • Janssen Pharmaceuticals, Inc. (Belgium)
  • Bristol Myers Squibb Company (U.S.)
  • Bayer AG (Germany)
  • Healthy Life Pharma Private Limited (India)
  • Drip Drop Hydration Inc. (U.S.)
  • Otsuka America Pharmaceutical, Inc (Japan)
  • Pendopharm (Canada)


SKU-
Why Choose Us


Frequently Asked Questions

The global oral electrolyte solutions market is projected USD 27 billion by 2029.
The Oral Electrolyte Solutions market is to grow at a CAGR of 13% during the forecast by 2029.
The major players operating in the Oral Electrolyte Solutions market are Johnsons & Johnsons Pvt Ltd (U.S.), Boehringer Ingelheim International GmbH (U.S.), Allergan (U.S.), Sun Pharmaceutical Industries Ltd. (India), Sanofi (France), Novartis AG (Switzerland), Pfizer Inc. (U.S.), Amneal Pharmaceuticals LLC. (U.S.), Mylan N.V. (U.S.), Janssen Pharmaceuticals, Inc. (Belgium), Bristol Myers Squibb Company (U.S.), Bayer AG (Germany), Healthy Life Pharma Private Limited (India), Drip Drop Hydration Inc. (U.S.), Otsuka America Pharmaceutical, Inc (Japan), Pendopharm (Canada).
The major countries covered in the Oral Electrolyte Solutions market are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.